Paskas, S.; Stockmann, P.; Mijatović, S.; Kuhnert, L.; Honscha, W.; Hey-Hawkins, E.; Maksimović-Ivanić, D.
Carborane-Based ABCG2-Inhibitors Sensitize ABC-(Over)Expressing Cancer Cell Lines for Doxorubicin and Cisplatin. Pharmaceuticals 2023, 16, 1582.
https://doi.org/10.3390/ph16111582
AMA Style
Paskas S, Stockmann P, Mijatović S, Kuhnert L, Honscha W, Hey-Hawkins E, Maksimović-Ivanić D.
Carborane-Based ABCG2-Inhibitors Sensitize ABC-(Over)Expressing Cancer Cell Lines for Doxorubicin and Cisplatin. Pharmaceuticals. 2023; 16(11):1582.
https://doi.org/10.3390/ph16111582
Chicago/Turabian Style
Paskas, Svetlana, Philipp Stockmann, Sanja Mijatović, Lydia Kuhnert, Walther Honscha, Evamarie Hey-Hawkins, and Danijela Maksimović-Ivanić.
2023. "Carborane-Based ABCG2-Inhibitors Sensitize ABC-(Over)Expressing Cancer Cell Lines for Doxorubicin and Cisplatin" Pharmaceuticals 16, no. 11: 1582.
https://doi.org/10.3390/ph16111582
APA Style
Paskas, S., Stockmann, P., Mijatović, S., Kuhnert, L., Honscha, W., Hey-Hawkins, E., & Maksimović-Ivanić, D.
(2023). Carborane-Based ABCG2-Inhibitors Sensitize ABC-(Over)Expressing Cancer Cell Lines for Doxorubicin and Cisplatin. Pharmaceuticals, 16(11), 1582.
https://doi.org/10.3390/ph16111582